A new tool for Cystic Fibrosis

Alaxia announces today its product, meveol, has been tested successfully by an independant lab on strong strains including mucoid pseudomonas, burkholderia, MRSA both In Vitro and In Vivo Meveol targets to compensate natural host defence defective in cystic fibrosis (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - Category: Respiratory Medicine Source Type: news